Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trial

Author(s):
Berg, H. van den; Paulussen, M.; Teuff, G. le; Judson, I.; Gelderblom, H.; Dirksen, U.; Brennan, B.; Whelan, J.; Ladenstein, R.L.; Marec-Berard, P.; Kruseova, J.; Hjorth, L.; Kuhne, T.; Brichard, B.; Wheatley, K.; Craft, A.; Juergens, H.; Gaspar, N.; Deley, M.C. le; Euro-EWING99 Grp
Published
2015
Publication type
Article / Letter to editor
Ewing sarcomasAlkylating agentGenderEfficacyToxicityInteractionMetabolismConstitutive androstane receptorCYP3A4CYP2B6
Date issued
2015-11-30
Language
English
Is part of
European Journal of Cancer (2015), Vol. 51, no. 16, p. 2453-2464
hdl
1887/107945
doi
10.1016/j.ejca.2015.06.123